162 related articles for article (PubMed ID: 7829610)
1. The corticotropin-releasing hormone (CRH) in normal and tumoral epithelial cells of human endometrium.
Makrigiannakis A; Zoumakis E; Margioris AN; Theodoropoulos P; Stournaras C; Gravanis A
J Clin Endocrinol Metab; 1995 Jan; 80(1):185-9. PubMed ID: 7829610
[TBL] [Abstract][Full Text] [Related]
2. Presence of immunoreactive corticotropin-releasing hormone in human endometrium.
Mastorakos G; Scopa CD; Kao LC; Vryonidou A; Friedman TC; Kattis D; Phenekos C; Rabin D; Chrousos GP
J Clin Endocrinol Metab; 1996 Mar; 81(3):1046-50. PubMed ID: 8772574
[TBL] [Abstract][Full Text] [Related]
3. Endometrial corticotropin-releasing hormone: expression, regulation, and potential physiological implications.
Makrigiannakis A; Psychoyos A; Zoumakis E; Margioris AN; Stournaras C; Gravanis A
Ann N Y Acad Sci; 1997 Jun; 816():116-28. PubMed ID: 9238261
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus.
Makrigiannakis A; Margioris AN; Le Goascogne C; Zoumakis E; Nikas G; Stournaras C; Psychoyos A; Gravanis A
Life Sci; 1995; 57(20):1869-75. PubMed ID: 7475934
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone and proopiomelanocortin-derived peptides are present in human myometrium.
Clifton VL; Telfer JF; Thompson AJ; Cameron IT; Teoh TG; Lye SJ; Challis JR
J Clin Endocrinol Metab; 1998 Oct; 83(10):3716-21. PubMed ID: 9768689
[TBL] [Abstract][Full Text] [Related]
6. The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines.
Makrigiannakis A; Margioris AN; Zoumakis E; Stournaras C; Gravanis A
Neuroendocrinology; 1999 Dec; 70(6):451-9. PubMed ID: 10657738
[TBL] [Abstract][Full Text] [Related]
7. Urocortin expression is downregulated in human endometrial carcinoma.
Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
[TBL] [Abstract][Full Text] [Related]
8. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
Arnold JT; Lessey BA; Seppälä M; Kaufman DG
Cancer Res; 2002 Jan; 62(1):79-88. PubMed ID: 11782363
[TBL] [Abstract][Full Text] [Related]
9. CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway.
Graziani G; Tentori L; Portarena I; Barbarino M; Tringali G; Pozzoli G; Navarra P
Endocrinology; 2002 Mar; 143(3):807-13. PubMed ID: 11861501
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells.
Makrigiannakis A; Zoumakis E; Margioris AN; Stournaras C; Chrousos GP; Gravanis A
Neuroendocrinology; 1996 Aug; 64(2):85-92. PubMed ID: 8857602
[TBL] [Abstract][Full Text] [Related]
11. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormones regulate the release of immunoreactive beta-endorphin from the Ishikawa human endometrial cell line.
Makrigiannakis A; Margioris A; Markogiannakis E; Stournaras C; Gravanis A
J Clin Endocrinol Metab; 1992 Aug; 75(2):584-9. PubMed ID: 1639959
[TBL] [Abstract][Full Text] [Related]
13. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells.
Di Blasio AM; Pecori Giraldi F; Viganò P; Petraglia F; Vignali M; Cavagnini F
J Clin Endocrinol Metab; 1997 May; 82(5):1594-7. PubMed ID: 9141555
[TBL] [Abstract][Full Text] [Related]
14. Endometrial and placental CRH as regulators of human embryo implantation.
Makrigiannakis A; Zoumakis E; Kalantaridou S; Chrousos G
J Reprod Immunol; 2004 Jun; 62(1-2):53-9. PubMed ID: 15288181
[TBL] [Abstract][Full Text] [Related]
15. Identification of a signaling pathway involving progesterone receptor, calcitonin, and tissue tranglutaminase in Ishikawa endometrial cells.
Li Q; Bagchi MK; Bagchi IC
Endocrinology; 2006 May; 147(5):2147-54. PubMed ID: 16439457
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
17. Cycle and age-related changes in corticotropin-releasing hormone levels in human endometrium and ovaries.
Zoumakis E; Chatzaki E; Charalampopoulos I; Margioris AN; Angelakis E; Koumantakis E; Gravanis A
Gynecol Endocrinol; 2001 Apr; 15(2):98-102. PubMed ID: 11379015
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing hormone receptor-1 in human endometrial cancer.
Graziani G; Ferrandina G; Pozzoli G; Vergati M; Muzi A; Legge F; Tentori L; Scambia G; Navarra P
Oncol Rep; 2006 Feb; 15(2):375-9. PubMed ID: 16391857
[TBL] [Abstract][Full Text] [Related]
19. Endometrial corticotropin-releasing hormone. Its potential autocrine and paracrine actions.
Zoumakis E; Makrigiannakis A; Margioris AN; Stournaras C; Gravanis A
Ann N Y Acad Sci; 1997 Sep; 828():84-94. PubMed ID: 9329825
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus].
Yue Y; Piao JX; Wang LN; Pu JW; Gao FD
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]